These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18310801)

  • 41. Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox.
    Abzug MJ; Pelton SI
    J Infect Dis; 2009 Apr; 199(8):1109-11. PubMed ID: 19265480
    [No Abstract]   [Full Text] [Related]  

  • 42. National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Burgmann H; Georgopoulos A; Vécsei A; Kollaritsch H
    Vaccine; 2009 Jun; 27(30):3963-8. PubMed ID: 19393711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preventing pneumococcal disease.
    Thomas R
    Can Fam Physician; 1998 Oct; 44():2180-1, 2184-5. PubMed ID: 9805173
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of television advertising in increasing pneumococcal vaccination coverage among the elderly, North Coast, New South Wales, 2006.
    Wallace C; Corben P; Turahui J; Gilmour R
    Aust N Z J Public Health; 2008 Oct; 32(5):467-70. PubMed ID: 18959552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.
    Tam JC; Grant NL; Freire-Moran L; Tolmie H; French N; Gordon SB
    J Allergy Clin Immunol; 2009 Jun; 123(6):1420-1. PubMed ID: 19423153
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of pneumococcal vaccination on chronic lymphocytic leukemia: should we rely on surrogate markers?
    Sinisalo M; Vilpo J; Itälä M; Väkeväinen M; Taurio J; Aittoniemi J
    Vaccine; 2008 Jul; 26(32):3959. PubMed ID: 18514977
    [No Abstract]   [Full Text] [Related]  

  • 48. Streptococcus pneumoniae incidence in western Europe.
    Salleras L; Domínguez A
    Lancet Infect Dis; 2007 Apr; 7(4):242-3; author reply 243-4. PubMed ID: 17376378
    [No Abstract]   [Full Text] [Related]  

  • 49. [An antipneumococcal vaccination program for the elderly of Bologna].
    Roveri P; Faggioli A; Gianninoni AR; Agostini D
    Ann Ig; 1999; 11(4):319-27. PubMed ID: 10520525
    [No Abstract]   [Full Text] [Related]  

  • 50. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
    Hsieh YC; Lin PY; Chiu CH; Huang YC; Chang KY; Liao CH; Chiu NC; Chuang YC; Chen PY; Chang SC; Liu JW; Yen MY; Wang JH; Liu CY; Lin TY
    Vaccine; 2009 Sep; 27(40):5513-8. PubMed ID: 19615960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pneumococcal vaccination in adults.
    Artz AS; Ershler WB
    JAMA; 2001 Jul; 286(2):166-7. PubMed ID: 11448274
    [No Abstract]   [Full Text] [Related]  

  • 53. Make pneumococcal immunization a priority.
    Gold J; Spurlin D
    WMJ; 2001; 100(9):62, 66. PubMed ID: 11868522
    [No Abstract]   [Full Text] [Related]  

  • 54. Improving pneumococcal vaccination rates for elderly patients.
    Gruber T; Marada R
    N J Med; 2000 Feb; 97(2):35-9. PubMed ID: 10697385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pneumococcal vaccine is effective].
    Flaegstad T
    Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1379. PubMed ID: 18552896
    [No Abstract]   [Full Text] [Related]  

  • 56. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination.
    Vila-Córcoles A
    J Intern Med; 2009 Nov; 266(5):432-44. PubMed ID: 19754854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pneumococcal prophylaxis for children with sickle cell disease in Africa.
    de Montalembert M; Brousse V; Zahar JR
    Arch Dis Child; 2008 Aug; 93(8):715-6. PubMed ID: 18644941
    [No Abstract]   [Full Text] [Related]  

  • 59. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.